Literature DB >> 8281987

Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines.

A Członkowski1, C Stein, A Herz.   

Abstract

It has been shown previously that opioids induce antinociceptive effects at peripheral sites in the presence of inflammatory processes. Besides being elicited by local injection of opioids, such effects can also be obtained by activation of intrinsic opioid mechanisms, e.g. following stress. In the present study the possible role of cytokines in this mechanism was investigated. Unilateral inflammation of the hindpaw of rats was induced by local injection of Freund's complete adjuvant. Intraplantar injection of tumor necrosis factor alpha (TNF alpha) or interleukin-6 induced a dose-dependent increase in the threshold in the paw pressure test in the inflamed but not in the non-inflamed paw. This increase was prevented by local injection of naloxone and the mu-opioid receptor specific antagonist CTOP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) as well as by 3-E7, an universal opioid peptide antibody. In rats pretreated with cyclosporin A to suppress the immune system, the antinociceptive effect of TNF alpha was completely inhibited. In concert with previous studies these data indicate that the tested cytokines release opioid peptides (e.g. beta-endorphin and/or enkephalins) from immune cells of the inflamed tissue which act on opioid receptors present on sensory nerve terminals, resulting in antinociception.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8281987     DOI: 10.1016/0014-2999(93)90246-e

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  27 in total

1.  Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats.

Authors:  P J Cabot; L Carter; C Gaiddon; Q Zhang; M Schäfer; J P Loeffler; C Stein
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 2.  Mode of action of cytokines on nociceptive neurons.

Authors:  Nurcan Uçeyler; Maria Schäfers; Claudia Sommer
Journal:  Exp Brain Res       Date:  2009-03-17       Impact factor: 1.972

Review 3.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

4.  Early Repeated Administration of CXCR4 Antagonist AMD3100 Dose-Dependently Improves Neuropathic Pain in Rats After L5 Spinal Nerve Ligation.

Authors:  Fang Xie; Yun Wang; Xueyang Li; Yu-Chieh Chao; Yun Yue
Journal:  Neurochem Res       Date:  2016-05-11       Impact factor: 3.996

5.  A Role for Inflammation in Chronic Pain.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

6.  Effect of opium use on short-term outcome in patients undergoing coronary artery bypass surgery.

Authors:  Nasser Safaii; Babak Kazemi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-02-13

Review 7.  IL-4, JAK-STAT signaling, and pain.

Authors:  Melanie Busch-Dienstfertig; Sara González-Rodríguez
Journal:  JAKSTAT       Date:  2014-01-02

8.  The Red Nucleus Interleukin-6 Participates in the Maintenance of Neuropathic Pain Induced by Spared Nerve Injury.

Authors:  Cui-Ping Ding; Yu-Shun Xue; Jing Yu; Yi-Jie Guo; Xiao-Yan Zeng; Jun-Yang Wang
Journal:  Neurochem Res       Date:  2016-08-03       Impact factor: 3.996

9.  The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care.

Authors:  Cielito C Reyes-Gibby; Badi El Osta; Margaret R Spitz; Henrique Parsons; Razelle Kurzrock; Xifeng Wu; Sanjay Shete; Eduardo Bruera
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

10.  The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.

Authors:  J L Wilson; V Nayanar; J S Walker
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.